Nephrol Dial Transplant (2000) 15: 2000-2006
© 2000 European Renal Association-European Dialysis and Transplant Association
Epidemiology of end-stage renal disease in the Ile-de-France area: a prospective study in 1998
1 Department of Nephrology, 2 INSERM U 507 and 3 Department of Biostatistics, Necker Hospital, Paris, France
Background. The objective of this study was to determine the incidence and prevalence of end-stage renal disease (ESRD) requiring maintenance dialysis in the Ile-de-France district (Paris area), and the characteristics of patients at start of dialysis.
Methods. This is a prospective epidemiological study with the cooperation of all dialysis facilities of the Ile-de-France district (population 10.7 million inhabitants as of March 1999). All consecutive ESRD patients who started dialysis from January 1 to December 31 1998, with demographic and clinical characteristics, and of the total number of patients on dialysis with their distribution according to dialysis modality were recorded.
Results. The total number of ESRD patients in 1998 was 1155, including 29 (2.5%) children aged 
17 years and 86 (7.4%) returns to dialysis following kidney graft failure. Incidence of first-dialysed patients was 100 per million population (p.m.p.) and overall incidence, including returns from transplantation, was 108 p.m.p. The mean age of first-dialysed adult patients was 59.8±16.8 years, with 21.6% aged 
75 years. Patients with vascular renal disease were 22.5% and those with diabetic nephropathy 20.6%. As a whole, 36.5% of patients were referred to the nephrologist 6 months before start of dialysis, including 32.2% referred 1 month before starting. Prevalence of cardiovascular disease was nearly twice as high in patients referred <6 months of starting dialysis than in those who benefited from effective nephrological care for >3 years in the predialysis period. By multivariate analysis, this difference persisted after adjustment for age and other confounding covariates. The total number of patients on maintenance dialysis increased from 417 to 433 p.m.p. (a yearly 3.8% increase) from the beginning to the end of 1998.
Conclusion. This recent epidemiological study in a large French urban area indicates an annual incidence of 100 new ESRD patients p.m.p., with a high proportion of older, vascular and diabetic patients. Overall incidence, including returns from transplantation, reached 108 p.m.p. Cardiovascular disease was significantly less frequent in patients who received nephrological care for 3 years prior to start of dialysis than in late referred patients, underlining the benefits of early nephrological management of renal patients.
Keywords: ESRD; France; Ile-de-France; incidence of ESRD; prevalence of dialysis patients; renal replacement therapy requirements
Correspondence and offprint requests to: Prof. Paul Jungers, Département de Néphrologie, Hôpital Necker, 149, rue de Sèvres, F-75743 Paris Cedex 15, France.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  R. Perez-Garcia, A. Martin-Malo, J. Fort, X. Cuevas, F. Llados, J. Lozano, F. Garcia, and on behalf of all Investigators from the ANSWER stu Baseline characteristics of an incident haemodialysis population in Spain: results from ANSWER--a multicentre, prospective, observational cohort study Nephrol. Dial. Transplant., February 1, 2009; 24(2): 578 - 588. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. K.-T. Li, M. C. Law, K. M. Chow, C.-B. Leung, B. C.-H. Kwan, K. Y. Chung, and C.-C. Szeto GOOD PATIENT AND TECHNIQUE SURVIVAL IN ELDERLY PATIENTS ON CONTINUOUS AMBULATORY PERITONEAL DIALYSIS Perit. Dial. Int., June 1, 2007; 27(Supplement_2): S196 - S201. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. Sprangers, P. Evenepoel, and Y. Vanrenterghem Late Referral of Patients With Chronic Kidney Disease: No Time to Waste Mayo Clin. Proc., November 1, 2006; 81(11): 1487 - 1494. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Jacobs Costs and benefits of improving renal failure treatment--where do we go? Nephrol. Dial. Transplant., August 1, 2006; 21(8): 2049 - 2052. [Full Text] [PDF]
|
|
|
|
|
|
C. Couchoud, B. Stengel, P. Landais, J.-C. Aldigier, F. de Cornelissen, C. Dabot, H. Maheut, V. Joyeux, M. Kessler, M. Labeeuw, et al. The renal epidemiology and information network (REIN): a new registry for end-stage renal disease in France Nephrol. Dial. Transplant., February 1, 2006; 21(2): 411 - 418. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. J. Palmer, D. M. D. Tucker, W. J. Valentine, S. Roze, S. Gabriel, and D. J. Cordonnier Cost-effectiveness of irbesartan in diabetic nephropathy: a systematic review of published studies Nephrol. Dial. Transplant., June 1, 2005; 20(6): 1103 - 1109. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Villar, M. Rabilloud, F. Berthoux, P. Vialtel, M. Labeeuw, and C. Pouteil-Noble A multicentre study of registration on renal transplantation waiting list of the elderly and patients with type 2 diabetes Nephrol. Dial. Transplant., January 1, 2004; 19(1): 207 - 214. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. J. Palmer, L. Annemans, S. Roze, M. Lamotte, R. A. Rodby, and D. J. Cordonnier An economic evaluation of irbesartan in the treatment of patients with type 2 diabetes, hypertension and nephropathy: cost-effectiveness of Irbesartan in Diabetic Nephropathy Trial (IDNT) in the Belgian and French settings Nephrol. Dial. Transplant., October 1, 2003; 18(10): 2059 - 2066. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Stengel, S. Billon, P. C.W. van Dijk, K. J. Jager, F. W. Dekker, K. Simpson, and J. D. Briggs Trends in the incidence of renal replacement therapy for end-stage renal disease in Europe, 1990-1999 Nephrol. Dial. Transplant., September 1, 2003; 18(9): 1824 - 1833. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. J. Collins Anaemia management prior to dialysis: cardiovascular and cost-benefit observations Nephrol. Dial. Transplant., June 1, 2003; 18(suppl_2): ii2 - ii6. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Joly, D. Anglicheau, C. Alberti, A.-T. Nguyen, M. Touam, J.-P. Grunfeld, and P. Jungers Octogenarians Reaching End-Stage Renal Disease: Cohort Study of Decision-Making and Clinical Outcomes J. Am. Soc. Nephrol., April 1, 2003; 14(4): 1012 - 1021. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Roderick, C. Jones, C. Tomson, and J. Mason Late referral for dialysis: improving the management of chronic renal disease QJM, June 1, 2002; 95(6): 363 - 370. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Jungers Late referral: loss of chance for the patient, loss of money for society Nephrol. Dial. Transplant., March 1, 2002; 17(3): 371 - 375. [Full Text] [PDF]
|
|